Paul Aiyetan
CEO
NEOPATHOLOGY CORP.
The startup develops a tissue diagnostics tool that utilizes specialized staining techniques, advanced microscopy, and AI-driven analysis to enhance the precision of disease diagnosis. By providing pathologists with detailed insights into tissue samples, the technology aims to improve treatment accuracy and clinical outcomes.
- Artificial Intelligence
- Healthcare Technology
- Software Only
Updated 6 months ago
Funding
Raised to date
$830KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a tissue diagnostics tool that utilizes specialized staining techniques, advanced microscopy, and AI-driven analysis to enhance the precision of disease diagnosis. By providing pathologists with detailed insights into tissue samples, the technology aims to improve treatment accuracy and clinical outcomes.